journal article·2018-07-04Open access

Comparison of anticancer activity of biocompatible ZnO nanoparticles prepared by solution combustion synthesis using aqueous leaf extracts ofAbutilon indicum, Melia azedarach and Indigofera tinctoriaas biofuels

G. K. Prashanth, P. A. Prashanth, B. M. Nagabhushana, S. Ananda, G. M. Krishnaiah, H. G. Nagendra, H. M. Sathyananda, C. Rajendra Singh, S. Yogisha, S. Anand, Y. Tejabhiram

Abstract

Recently, there has been an upsurge in the use of naturally available fuels for solution combustion synthesis (SCS) of nanoparticles. Although many reports suggest that these biofuels pose less harm to the environment, their strategic advantages and reliability for making NPs has not been discussed. In the present work, we try to address this issue using plant extracts as biofuels for the SCS of zinc oxide nanoparticles as a model system. In the present work, combustion synthesis of ZnO NPs using lactose and aqueous leaf extracts of Abutilon indicum, Melia azedarach, Indigofera tinctoria as biofuels has been carried out. A comparative analysis of the obtained powders has been conducted to understand the strategic advantages of using plant extracts over a chemical as combustion fuel for the synthesis of zinc oxide nanoparticles. The X-ray diffractograms of the samples revealed the presence of Wurtzite hexagonal structure with varying crystallite sizes. Morphological studies indicated that samples prepared using biofuels had smaller diameter than those prepared using lactose as fuel. Surface characteristics of the samples were measured by X-ray photoelectron spectroscopy. Qualitative phytochemical screening of aqueous leaf extracts revealed the presence of many phytochemicals in them, which might be responsible for combustion. Gas chromatography mass spectrum was carried out to detect the phytochemicals present in the aqueous extracts of the leaves. Further, anticancer evaluation carried out against DU-145 and Calu-6 cancer cells indicated higher anticancer activity of zinc oxide nanoparticles prepared using biofuels. The results of blood haemolysis revealed the biocompatibility of zinc oxide nanoparticles at lower concentrations. In conclusion, we propose that multiple other studies would be required in order to vindicate the potential advantages of using naturally available fuels in SCS.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Sir M. Visvesvaraya Institute of Technology, Bengaluru, India;

Research and Development Centre, Bharathiar University, Coimbatore, India;

Department of Chemistry, Sai Vidya Institute of Technology, Bengaluru, India;

Department of Chemistry, M. S. Ramaiah Institute of Technology, Bengaluru, India;

Department of Chemistry, University of Mysore, Mysuru, India;

Department of Bio Technology, Sir M. Visvesvaraya Institute of Technology, Bengaluru, India;

Drug Discovery Research and Development Centre, Skanda Life Sciences Private Limited, Bengaluru, India;

Nanotechnology Research Centre, SRM University, Chennai, India

References (52)

Show source-provided references
1. 10.1016/j.jallcom.2014.12.23210.1016/j.jallcom.2014.12.232 ↗
2. 10.1016/j.ultsonch.2015.09.02110.1016/j.ultsonch.2015.09.021 ↗
3. 10.1016/j.jfda.2015.02.00910.1016/j.jfda.2015.02.009 ↗
4. 10.1002/adma.20130173210.1002/adma.201301732 ↗
5. 10.1080/21691401.2017.128286810.1080/21691401.2017.1282868 ↗
6. 10.1016/j.antiviral.2012.09.02010.1016/j.antiviral.2012.09.020 ↗
7. 10.1016/j.nano.2016.08.01610.1016/j.nano.2016.08.016 ↗
8. 10.1080/21691401.2017.133702510.1080/21691401.2017.1337025 ↗
9. Nehru LC · J Ceramic Processing Res · 2013 · 6 · 712
10. 10.1007/s10008000015710.1007/s100080000157 ↗
11. 10.1016/S1359-0286(02)00123-710.1016/S1359-0286(02)00123-7 ↗
12. 10.1142/675410.1142/6754 ↗
13. Parashar UK · Digest J Nanomater Biostruct · 2009 · 4 · 159
14. 10.1016/j.colsurfb.2009.01.01210.1016/j.colsurfb.2009.01.012 ↗
15. Forough M · Turkish J Env Sci · 2010 · 34 · 281
16. 10.1088/0957-4484/23/45/45510310.1088/0957-4484/23/45/455103 ↗
17. 10.1039/c2ra22299j10.1039/c2ra22299j ↗
18. 10.7150/thno.781910.7150/thno.7819 ↗
19. 10.1039/c1jm11592h10.1039/c1jm11592h ↗
20. 10.1039/b303808b10.1039/b303808b ↗
21. 10.1166/jbn.2005.01210.1166/jbn.2005.012 ↗
22. 10.1016/j.msec.2015.04.04810.1016/j.msec.2015.04.048 ↗
23. 10.1016/j.saa.2011.05.00110.1016/j.saa.2011.05.001 ↗
24. 10.1007/s11051-011-0230-510.1007/s11051-011-0230-5 ↗
25. 10.1016/j.kijoms.2015.10.00710.1016/j.kijoms.2015.10.007 ↗
26. 10.1080/21691401.2016.120379510.1080/21691401.2016.1203795 ↗
27. 10.1080/21691401.2017.133263510.1080/21691401.2017.1332635 ↗
28. 10.1080/21691401.2016.122866310.1080/21691401.2016.1228663 ↗
29. Yoganarasimhan SN. · 2010
30. 10.1021/jf500054f10.1021/jf500054f ↗
31. 10.5455/jeim.060612.or.03210.5455/jeim.060612.or.032 ↗
32. 10.1080/21691401.2017.129064310.1080/21691401.2017.1290643 ↗
33. Prashanth GK · Adv Mat Lett · 2017 · 8 · 2410.5185/amlett.2017.6424 ↗
34. 10.1186/1556-276X-8-49610.1186/1556-276X-8-496 ↗
35. 10.1166/asem.2016.185410.1166/asem.2016.1854 ↗
36. 10.1186/1556-276X-7-60210.1186/1556-276X-7-602 ↗
37. 10.1016/j.msec.2016.02.03910.1016/j.msec.2016.02.039 ↗
38. 10.1016/j.msec.2017.02.09310.1016/j.msec.2017.02.093 ↗
39. Kokate CK. · 2000
40. Harbone JB. · 1999
41. Tiwari P · Internationale Pharmaceutica Sciencia · 2011 · 1 · 98
42. 10.1016/j.colsurfb.2013.06.04110.1016/j.colsurfb.2013.06.041 ↗
43. Mishra A · Trends Biomater Artificial Organs · 2010 · 23 · 122
44. 10.1016/j.jallcom.2011.10.09410.1016/j.jallcom.2011.10.094 ↗
45. Saraswathi R · Int J Pharmacy Pharm Sci · 2011 · 3 · 154
46. Bhargava S. · Indochemical J Pharm Res · 2013 · 3 · 4310
47. Ahmed MF · Int J Pharm Appl · 2012 · 3 · 271
48. Chopra C. · Indian J Pharmacol · 1956 · 8 · 416
49. 10.1016/j.nano.2010.10.00110.1016/j.nano.2010.10.001 ↗
50. 10.1088/0957-4484/19/29/29510310.1088/0957-4484/19/29/295103 ↗
51. 10.1021/nl080561510.1021/nl0805615 ↗
52. 10.1016/S0142-9612(01)00228-910.1016/S0142-9612(01)00228-9 ↗